Who owns LEXEO THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Lexeo Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Lexeo Therapeutics stock

Who bought or sold LEXEO THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Henderson Group 3.2M $51M 25% Jun 2024
 View chart
Citadel Advisors 2.7M $25M 6% Sep 2024
 View chart
Omega Fund Management 2.4M $38M 0% Jun 2024
 View chart
Eventide Asset Management 1.9M $17M -45% Sep 2024
 View chart
BlackRock 1.6M $15M 100% Sep 2024
 View chart
Frazier Life Sciences Management 1.3M $11M 100% Sep 2024
 View chart
Blackstone Group 1.2M $11M 44% Sep 2024
 View chart
Novo A/S 1.1M $10M -23% Sep 2024
 View chart
Woodline Partners 852k $7.7M 3% Sep 2024
 View chart
Vestal Point Capital 850k $7.7M 1% Sep 2024
 View chart
BlackRock 792k $13M 19% Jun 2024
 View chart
Braidwell 729k $6.6M -47% Sep 2024
 View chart
Vanguard Group 630k $10M 31% Jun 2024
 View chart
Siren 603k $5.5M 100% Sep 2024
 View chart
Geode Capital Management 553k $5.0M 87% Sep 2024
 View chart
RA Capital Management 547k $4.9M -19% Sep 2024
 View chart
Verition Fund Management 421k $6.8M 593% Jun 2024
 View chart
Point72 Asset Management 370k $3.3M 100% Sep 2024
 View chart
Laurion Capital Management 260k $2.4M -43% Sep 2024
 View chart
Ikarian Capital 257k $2.3M 100% Sep 2024
 View chart
DAFNA Capital Management 251k $2.3M 100% Sep 2024
 View chart
Northern Trust 200k $1.8M 144% Sep 2024
 View chart
State Street Corporation 196k $3.1M 75% Jun 2024
 View chart
Perceptive Advisors 140k $1.3M 100% Sep 2024
 View chart
Charles Schwab Investment Management 64k $577k 107% Sep 2024
 View chart
Polar Securities 60k $541k -8% Sep 2024
 View chart
Barclays 50k $454k 162% Sep 2024
 View chart
Bank of New York Mellon 48k $434k 51% Sep 2024
 View chart
Bank of America Corporation 39k $351k 165% Sep 2024
 View chart
Jane Street 36k $323k 33% Sep 2024
 View chart
Jacobs Levy Equity Management 30k $274k 100% Sep 2024
 View chart
Goldman Sachs Group 27k $431k 14% Jun 2024
 View chart
PDT Partners 27k $241k 100% Sep 2024
 View chart
Citigroup 23k $209k 100% Sep 2024
 View chart
Rhumbline Advisers 21k $191k 58% Sep 2024
 View chart
Nuveen Asset Management 18k $293k 36% Jun 2024
 View chart
MetLife Investment Advisors 14k $129k 122% Sep 2024
 View chart
Mirae Asset Global Etfs Holdings 13k $116k 164% Sep 2024
 View chart
Morgan Stanley 13k $203k -9% Jun 2024
 View chart
Alliancebernstein 11k $172k 100% Jun 2024
 View chart
Jpmorgan Chase & Co 10k $93k 136% Sep 2024
 View chart
Values First Advisors 7.4k $67k 100% Sep 2024
 View chart
Wells Fargo & Company 7.4k $67k 123% Sep 2024
 View chart
Bnp Paribas Arbitrage, Snc 5.5k $50k 184% Sep 2024
 View chart
Deutsche Bank Aktiengesellschaft 4.8k $44k 6% Sep 2024
 View chart
New York State Common Retirement Fund 4.2k $38k 0% Sep 2024
 View chart
Royal Bank of Canada 3.2k $25k 226% Sep 2024
 View chart
Summit Investment Advisors 2.4k $22k 133% Sep 2024
 View chart
California State Teachers Retirement System 1.7k $16k 134% Sep 2024
 View chart
Tower Research Capital 1.6k $25k 211% Jun 2024
 View chart
Amalgamated Bank 623.00 $6.0k 0% Sep 2024
 View chart
Nelson, Van Denburg & Campbell Wealth Management 174.00 $1.6k 100% Sep 2024
 View chart
Lazard Asset Management 33.00 $0 0% Sep 2024
 View chart
Sterling Capital Management 27.00 $243.999000 100% Sep 2024
 View chart
SRS Capital Advisors 12.00 $108.999600 0% Sep 2024
 View chart
CWM 10.00 $0 -38% Sep 2024
 View chart

Who sold out of Lexeo Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Artal Group Jun 2024 603k $9.7M
Millennium Management Jun 2024 38k $601k
Franklin Resources Jun 2024 14k $225k
NISA Investment Advisors Jun 2024 32.00 $512.998400
GAMMA Investing Jun 2024 14.00 $224.999600